These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


153 related items for PubMed ID: 8755196

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A comparison of intravitreal piperacillin/tazobactam with ceftazidime in experimental Pseudomonas aeruginosa endophthalmitis.
    Ozkiriş A, Evereklioglu C, Akgün H, Eşel D, Caner F, Erkiliç K.
    Exp Eye Res; 2005 Mar; 80(3):361-7. PubMed ID: 15721618
    [Abstract] [Full Text] [Related]

  • 4. Dose response of experimental Pseudomonas endophthalmitis to ciprofloxacin, gentamicin, and imipenem: evidence for resistance to "late" treatment of infections.
    Davey PG, Barza M, Stuart M.
    J Infect Dis; 1987 Mar; 155(3):518-23. PubMed ID: 3100661
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The efficacy of intravitreal vancomycin and dexamethasone in the treatment of experimental bacillus cereus endophthalmitis.
    Liu F, Kwok AK, Cheung BM.
    Curr Eye Res; 2008 Sep; 33(9):761-8. PubMed ID: 18798079
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
    Engel LS, Callegan MC, Hobden JA, Reidy JJ, Hill JM, O'Callaghan RJ.
    Curr Eye Res; 1995 Mar; 14(3):229-34. PubMed ID: 7796606
    [Abstract] [Full Text] [Related]

  • 10. Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis.
    Ermis SS, Cetinkaya Z, Kiyici H, Inan UU, Ozturk F.
    Curr Eye Res; 2007 Apr; 32(4):337-44. PubMed ID: 17453955
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal piperacillin/tazobactam in the management of multidrug-resistant Pseudomonas aeruginosa endophthalmitis.
    Pathengay A, Mathai A, Shah GY, Ambatipudi S.
    J Cataract Refract Surg; 2010 Dec; 36(12):2210-1. PubMed ID: 21111328
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental endophthalmitis.
    De Kaspar HM, Ta CN, Engelbert M, Mette M, Thiel M, Kampik A.
    Retina; 2008 Feb; 28(2):326-32. PubMed ID: 18301039
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nona-D-arginine therapy for Pseudomonas aeruginosa keratitis.
    Karicherla P, Hobden JA.
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):256-62. PubMed ID: 18775859
    [Abstract] [Full Text] [Related]

  • 18. Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment.
    Bucher RS, Hall E, Reed DM, Richards JE, Johnson MW, Zacks DN.
    Arch Ophthalmol; 2005 May; 123(5):649-53. PubMed ID: 15883284
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.